PANDOLFO, Gianluca
 Distribuzione geografica
Continente #
EU - Europa 6.423
NA - Nord America 6.364
AS - Asia 3.374
SA - Sud America 1.152
AF - Africa 127
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.469
Nazione #
US - Stati Uniti d'America 6.247
IT - Italia 1.964
SG - Singapore 1.364
IE - Irlanda 1.210
SE - Svezia 1.097
CN - Cina 1.033
BR - Brasile 1.019
DE - Germania 496
HK - Hong Kong 425
PL - Polonia 288
FR - Francia 254
UA - Ucraina 249
FI - Finlandia 240
GB - Regno Unito 188
VN - Vietnam 169
RU - Federazione Russa 168
IN - India 88
NL - Olanda 60
CA - Canada 52
AR - Argentina 47
TR - Turchia 46
MX - Messico 43
ES - Italia 40
BE - Belgio 36
ZA - Sudafrica 36
BD - Bangladesh 31
EG - Egitto 31
JP - Giappone 27
UZ - Uzbekistan 27
AT - Austria 25
IQ - Iraq 25
MA - Marocco 23
ID - Indonesia 21
AU - Australia 20
EC - Ecuador 20
CZ - Repubblica Ceca 18
PK - Pakistan 18
CH - Svizzera 17
AE - Emirati Arabi Uniti 14
CO - Colombia 14
VE - Venezuela 14
LT - Lituania 12
BY - Bielorussia 10
DZ - Algeria 10
AZ - Azerbaigian 9
CL - Cile 9
LV - Lettonia 9
NP - Nepal 9
PE - Perù 9
PY - Paraguay 9
GR - Grecia 8
IL - Israele 7
BG - Bulgaria 6
CI - Costa d'Avorio 6
DO - Repubblica Dominicana 6
GE - Georgia 6
IR - Iran 6
KG - Kirghizistan 6
PH - Filippine 6
RO - Romania 6
JO - Giordania 5
KE - Kenya 5
MY - Malesia 5
PA - Panama 5
SN - Senegal 5
AL - Albania 4
BO - Bolivia 4
HN - Honduras 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
TN - Tunisia 4
UY - Uruguay 4
AM - Armenia 3
KZ - Kazakistan 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BN - Brunei Darussalam 2
CG - Congo 2
GY - Guiana 2
KH - Cambogia 2
LK - Sri Lanka 2
MK - Macedonia 2
NG - Nigeria 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
Totale 17.456
Città #
Dublin 1.209
Chandler 843
Dallas 752
Ashburn 749
Singapore 697
Nyköping 570
Jacksonville 512
Beijing 478
Hong Kong 422
Warsaw 273
Los Angeles 178
Dearborn 169
Princeton 164
Medford 160
Rome 160
Cambridge 142
The Dalles 141
Messina 135
New York 132
Munich 131
Bremen 126
Ann Arbor 124
Des Moines 118
Milan 116
Boardman 105
São Paulo 80
Buffalo 71
Houston 68
Turku 64
Catania 58
Redondo Beach 57
Ho Chi Minh City 50
Lancaster 49
Moscow 49
Jinan 44
Rio de Janeiro 42
Shenyang 40
Tianjin 39
Wilmington 38
Brussels 36
Frankfurt am Main 35
Hanoi 32
Padova 32
Helsinki 31
Naples 31
Udine 30
Woodbridge 30
Belo Horizonte 29
Cairo 28
Hyderabad 28
Palermo 28
San Mateo 28
Turin 28
Strasbourg 27
Brasília 26
Hebei 26
Bari 24
Dong Ket 24
Nanjing 24
Seattle 24
Tashkent 24
Zhengzhou 24
Brooklyn 23
Vienna 23
Johannesburg 22
Pune 22
Genoa 21
Tokyo 21
Stockholm 20
Amsterdam 19
Ningbo 19
Haikou 18
Hangzhou 18
Porto Alegre 18
Taizhou 18
Istanbul 17
London 17
Santa Clara 17
Toronto 17
Chicago 16
Phoenix 16
San Francisco 16
Taranto 16
Washington 16
Bologna 15
Curitiba 15
Denver 15
Guangzhou 15
Montreal 15
Düsseldorf 14
Nanchang 14
Orem 14
Poplar 14
Verona 14
Manchester 13
Mexico City 13
Brescia 12
Chennai 12
Fuzhou 12
Jakarta 12
Totale 10.633
Nome #
State-Trait Anger Expression Inventory (STAXI) e Defense Mechanisms Inventory (DMI): i limiti di un questionario di autovalutazione 405
Alessitimia, emozioni negative e comportamento sessuale 391
Efficacia di un trattamento aggiuntivo con olanzapina nel disturbo ossessivo-compulsivo resistente agli SSRI 355
Il Burnout e l'emozione rabbia. 195
Trattamento con agomelatina in soggetti affetti da fibromialgia: effetti sulla fenomenica depressiva, ansiosa e algica 180
Frazione polifenolica del bergamotto per il trattamento della sindrome metabolica nella schizofrenia: uno studio pilota [Bergamot polyphenolic fraction for the treatment of metabolic syndrome in schizophrenia: A pilot study] 180
JUVENILE CRIMINALITY AND EXECUTIVE COGNITIVE FUNCTIONING IN AN ITALIAN SAMPLE OF LATE-ONSET ADOLESCENT DELINQUENTS 177
Carcinoma mammario e disturbo depressivo. 168
Depressione e disturbi endocrini 167
Alessitimia, internet addiction disorder e mobile addiction in un campione di adolescenti 162
Abnormal illness behavior and Internet addiction severity: The role of disease conviction, irritability, and alexithymia. 162
Advanced glycation end-products and advanced oxidation protein products in schizophrenia 158
Indagine statistico-epidemiologica per l’analisi dei rischi dipsicopatologia in giovani affetti da diabete mellito di tipo 1 157
Depressione, ansia e rabbia in soggetti affetti da diabete mellito di tipo 1 [Depression, anxiety and anger in patients with type 1 diabetes mellitus] 157
Association of the COMT synonymous polymorphism Leu136Leu and missense variant Val158Met with mood disorders. 156
Personality, Alexithymia, and Anger in a sample of adults affected by Type 1 Juvenile-Onset Diabetes. 155
Valutazione dell’umore e della personalità in un campione di forti fumatori 150
Augmentation con Lamotrigina in pazienti con schizofrenia resistente in trattamento con Clozapina 146
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder 141
Augmentation con Aripiprazolo vs. placebo nel disturbo ossessivo compulsivo con sintomatologia residua in trattamento stabilizzato con SSRI 140
CORRELATION ANALYSIS BETWEEN PERSONALITY AND RESILIENCE IN NON CLINICAL SUBJECTS. 138
Acetyl-L-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia: A 12-Week, Open-Label Uncontrolled Preliminary Study 137
Extrasensory perception experiences and childhood trauma: A rorschach investigation 137
Reboxetine add-on to clozapine in treatment of negative symptoms of schizophrenia: a preliminary open-label study 136
Alexithymia, Negative Emotions, and Sexual Behavior in Heterosexual University Students from Italy 135
Morphometrical and morphological analysis of lateral ventricles in schizophrenia patients versus healthy controls. 134
Depression, anxiety and anger in subtypes of irritable bowel syndrome patients 132
Anger, Smoking Behavior, and the Mediator Effects of Gender: An Investigation of Heavy and Moderate Smokers. 132
Psychopharmacotherapy in pregnancy and breastfeeding 131
Comportamento sessuale ed immaginario erotico in donne tossicodipendenti. 130
Anger and Adolescence: A Psychometric Investigation on a Sample of Italian High School Students 130
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 130
Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study 129
Grief and the new DSM-5 clinical category: A narrative review of the literature. 127
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 125
Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study. 124
Anger in health, benign breast disease and breast cancer: a prospective case-control study. 124
Funzioni neuropsicologiche e dimensioni psicopatologiche (positiva, negativa e disorganizzata) della schizofrenia. 123
Cannabis and Sexual Behavior 122
The wounds of childhood: Early trauma subtypes, salience and hyperarousal in a sample of adult psychiatric patients 119
IL-33 in Mental Disorders 118
Temperamento e alessitimia in un campione di soggetti antisociali con condotte di abuso. 117
Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. XVII Congresso Nazionale della Società Italiana di Neuropsicofarmacologia, Cagliari 22-25 Settembre 2010, p. 47. 117
Augmentation of clozapine with agomelatine in partial-responder schizophrenia: A 16-week, open-label, uncontrolled pilot study 117
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 116
The relationship between sexual behavior and internet addiction severity in a sample of heterosexual university students from Italy. 116
Metabolic outcomes of Red yeast rice administration in patients treated with second-generation antipsychotics 115
Donepezil adjunctive treatment to clozapine for cognitive impairment in schizophrenia 113
Executive functions and basic symptoms in adolescent antisocial behavior: A cross-sectional study on an Italian sample of late-onset offenders. 113
The role of alexithymia factors in adults with autism spectrum disorder: An explorative study 113
Personality traits and emotional patterns in irritable bowel Syndrome 112
Esplorazione neuropsicologica del lobo prefrontale nel disturbo schizofrenico 111
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 111
The RS685012 Polymorphism of ACCN2, the Human Ortholog of Murine Acid-Sensing Ion Channel (ASIC1) Gene, is Highly Represented in Patients with Panic Disorder. 111
Bergamot Polyphenolic Fraction Supplementation Improves Cognitive Functioning in Schizophrenia 111
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 109
Complicated grief: A systematic review of the last 20 years 108
“Augmentation con Duloxetina vs. placebo in un campione di schizofrenici partial responders in trattamento stabilizzato con antipsicotici atipici”. 108
Attentional and mnestic resistance to interference and the positive, negative and disorganization dimensions of schizophrenia: a correlation study 107
Effetto di un trattamento con agomelatina sulle funzioni cognitive/esecutive di un campione di soggetti affetti da fibromialgia 107
Does personality matter? Temperament and character dimensions in panic subtypes 107
Antisocial personality disorder and subthresold symptomatology 106
Aripiprazole Plus Topiramate in Opioid-dependent Patients with Schizoaffective Disorder: An 8-week, Open-label, Uncontrolled, Preliminary Study 106
Indici psicodiagnostici dei disturbi dello spettro autistico in età adulta: risultati preliminari 106
Meccanismi di difesa (D.M.I.) e temperamento (T.C.I.): studio di correlazione. 105
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 105
L'instabilità affettiva nel Disturbo Borderline di Personalità e nella Ciclotimia. 104
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. 103
Criminalità giovanile: correlati neuropsicologici e psicopatologici. 102
Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia: A Double-Blind, Placebo-Controlled Study. 102
EW0245 Cognitive outcomes of Bergamot Polyphenolic Fraction (BPF) supplementation in schizophrenia: Preliminary data 102
Focus on Disruptive Mood Dysregulation Disorder: A review of the literature 102
Lifetime Psychiatric Comorbidity and Diagnostic Trajectories in an Italian Psychiatric Sample 100
Aspetti funzionali dei recettori D1 Mesocorticali 99
Indagine statistico-epidemiologica per l’analisi dei rischi di psicopatologia in adolescenti affetti da diabete mellito di tipo1. 99
P.6.d.006 Aripiprazole plus topiramate in opioiddependent patients with schizoaffective disorder: evidence from a pilot study 99
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 99
Esplorazione neuropsicologica delle funzioni esecutive 98
Pharmacokinetic interaction between duloxetine and second-generation antipsychotics in patients with psychotic disorders 98
P.4.d.002 Effect of ziprasidone augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder 98
Rabbia e meccanismi di difesa nel paziente in trattamento dialitico cronico: dati preliminari 97
Immaginario erotico e comportamento sessuale nelle donne: dati preliminari 97
Central serous chorioretinopathy and personality characteristics: A systematic review of scientific evidence over the last 10 years (2010 to 2020) 97
The Relationship between Anger and Heterosexual Behavior. An Investigation in a Nonclinical Sample of Urban Italian Undergraduates. 96
Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics. 95
Association between cortisol levels and pain threshold in systemic sclerosis and major depression 95
Correlazione tra sintomi di base e dimensione psicotica nel disturbo schizofrenico 94
Memoria ed attenzione nel disturbo ossessivo compulsivo: uno studio preliminare. 94
Effect of Ziprasidone Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: A 12-Week, Open-Label Uncontrolled Preliminary Study 94
Interference inhibition and relational complexity in schizophrenia 93
Indagine epidemiologica sui disturbi di personalità nella popolazione carceraria della casa circondariale di Messina 93
Rabbia e meccanismi di difesa 92
The Relationship Between Anger and Sexual Behavior: A Review of Theories and Research 92
The Role of Basic Symptoms and Aberrant Salience in Borderline Personality Disorder 92
Comportamento sessuale ed immaginario erotico ad un test proiettivo in un campione di donne messinesi. 91
Rabbia e meccanismi di difesa in un campione di tossicodipendenti in trattamento metadonico. 90
L'analisi della complessità relazionale nel disturbo schizofrenico 89
Effect of valproate on plasma concentrations of olanzapine in patients with psychotic disorders , July, 2009, MP 110.. 87
Avoidant personality disorder and delusions 87
null 87
Totale 12.639
Categoria #
all - tutte 62.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021615 0 0 0 0 0 135 65 95 65 111 74 70
2021/20221.319 22 145 30 51 58 12 74 52 66 273 152 384
2022/20233.523 230 334 155 226 379 335 38 182 1.469 40 96 39
2023/20241.321 93 160 103 134 112 245 57 64 36 99 71 147
2024/20253.964 70 77 151 261 191 180 92 732 916 214 418 662
2025/20263.845 654 709 818 667 910 87 0 0 0 0 0 0
Totale 17.739